Ignite Creation Date:
2025-12-24 @ 7:10 PM
Ignite Modification Date:
2026-02-22 @ 5:08 PM
Study NCT ID:
NCT03158103
Status:
COMPLETED
Last Update Posted:
2021-04-30
First Post:
2017-05-16
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study of MEK162 (Binimetinib) in Combination With Pexidartinib in Patients With Advanced Gastrointestinal Stromal Tumor (GIST)
Sponsor:
Memorial Sloan Kettering Cancer Center
Organization: